Even when hospitalized people with a STEMI heart attack receive the best possible care, complications or death are at risk. In contrast, in China, the traditional Chinese medicine Tongxinluo has been used for more than 25 years. A study more than a decade ago showed that it has a protective effect on heart muscle cells.
Prof. Yuejin Yang of Peking Union Medical College in Beijing presented data from a new, larger study at the annual meeting of the American Heart Association (AHA) that confirms this: The study involved nearly 3,800 patients from 124 clinics in China who also received either an ineffective drug (a placebo ) or used Tongxinluo for 12 months as usual treatment from the beginning. Significantly better results were observed with Tongxinluo both after 30 days and after one year.
The most important results were that 30 percent fewer heart attack patients died and 65 percent fewer heart attacks. Various other cardiovascular complications also occurred significantly less often. Serious side effects were observed in both groups with approximately the same frequency, so it can be assumed that they were not caused by the herbal medicine.
Since the drug has so far only been used and tested in China, further studies must show whether it is similarly effective in other population groups.
What: DOI 10.1016/j.ahj.2020.06.011